Partnering Centers and Departments
- Penn Memory Center (PMC)
- Penn brainSTIM Center
- Mahoney Institute for Neurosciences (MINS)
- Penn Neurogenetics Therapy Center
- Institute for Translational Medicine and Therapeutics (ITMAT)
- Penn’s Center for Neuroengineering & Therapeutics (CN&T)
- Institute on Aging (IOA)
- Center for Neurodegenerative Disease Research (CNDR)
- Alzheimer’s Disease Research Center (ADRC)
- Department of Neurology
- Department of Psychiatry
- Department of Neuroscience
- Department of Neurosurgery
The Penn Memory Center is a single, unified Penn Medicine source for those age 65 and older seeking evaluation, diagnosis, treatment, information, and research opportunities related to symptoms of progressive memory loss, and accompanying changes in thinking, communication and personality.
The Penn Brain Science, Translation, Innovation, and Modulation (brainSTIM) Center brings together a team of leading neuroscientists, neurologists, psychiatrists, psychologists, and engineers from the University of Pennsylvania who use groundbreaking neuromodulation techniques to research, repair, and enhance human brain function.
The Mahoney Institute for Neurosciences (MINS) at the University of Pennsylvania continues as one of the world's preeminent institutions for neuroscience research and training. Acting as the university's intellectual fulcrum for the study of the brain, MINS continues to support cross-disciplinary thinking and an integrated approach to fundamental, pre-clinical, and clinical research on the brain.
The mission of the Penn Neurogenetics Therapy Center (PNTC) is to catalyze the translation of genetic diagnosis into precision, gene-based therapeutics for people with neurogenetic disorders. This involves a team approach which allows us to provide a complete perspective, from making complex genetic diagnoses to seamless delivery of new genetic-based therapies as they become commercially available. The PNTC has a core team of experts including neurologists with basic science backgrounds and translational experience, genetic counselors, as well as clinical research supporting staff, including a director of operations, project managers, research nurses, coordinators and a finance specialist.
Institute for Translational Medicine and Therapeutics (ITMAT) supports research at the interface of basic and clinical research focusing on developing new and safer medicines. ITMAT includes faculty, basic research space, and the Center for Human Phenomic Science (CHPS), which includes both Penn and the Children's Hospital of Philadelphia (CHOP). ITMAT also offers research cores, research programs, research centers, and educational programs in clinical and translational science for researchers and research support staff.
Penn’s Center for Neuroengineering & Therapeutics is working to develop and test new devices that can restore brain and nervous system function after it has been lost to disease or disability.
The mission of the Institute on Aging (IOA) at the University of Pennsylvania is to improve the health of older adults by increasing the quality and quantity of clinical and basic research as well as educational programs focusing on normal aging and aging-related diseases across the entire Penn campus.
The mission of the Center for Neurodegenerative Disease Research (CNDR) is to promote and conduct multidisciplinary clinical and basic research to increase the understanding of the causes and mechanisms leading to brain dysfunction and degeneration in neurodegenerative diseases such as Alzheimer’s disease (AD), Parkinson’s disease (PD), Lewy body dementia (LBD), Frontotemporal degeneration (FTD), Amyotrophic lateral sclerosis (ALS), Primary lateral sclerosis (PLS), Motor neuron disease (MND), and related disorders that occur increasingly with advancing age. Implicit in the mission of the CNDR are two overarching goals: 1.) Find better ways to cure and treat these disorders, 2. Provide training to the next generation of scientists.
The mission of the Penn Alzheimer's Disease Research Center (ADRC) is to increase research and education on Alzheimer’s disease (AD) and its links to related dementias (ADRD) across the continuum of normal aging to dementia with the goal of identifying the causes of and cures for AD/ADRD. To achieve this, the Penn ADRC coordinates research programs, stimulates new research directions, provides community education and outreach, academic research training, and fosters the development of novel techniques to individualize diagnoses and treatments for the benefit of all older adults and their families. Penn's ADRC is a NIH-recognized ADRC.
The Department of Neurology has a strong mission and a rich history at the University of Pennsylvania. We have a long tradition of excellence in patient care, research and education in both adult and pediatric neurology. Since its establishment more than a century ago, our department has shaped the field of neurology by pioneering essential neurologic treatments and diagnostic techniques. Today, we are committed to our mission — to be a center of excellence and innovation dedicated to the pursuit of curing neurologic diseases through compassionate, patient-centered care, transformative research and education of the future leaders in neurology.
Penn Psychiatry develops and implements new ideas to understand, prevent and treat disorders of the brain and mind, through innovative research and discoveries, outstanding educational programs, world renowned clinical services, and transformational public health policies.
Our mission is to advance understanding of the nervous system through basic and translational research and to train the next generation of neuroscientists and physicians.
Penn Neurosurgery provides outstanding patient care, exceptional training and conducts the latest research for all conditions of the nervous system.